DR AGARWALS EYE HOSPITAL
|
DR AGARWALS EYE HOSPITAL Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 116.28 | 98.64 | 78.55 | 51.28 | -3.06 |
| CEPS(Rs) | 200.21 | 155.26 | 121.49 | 94.66 | 37.58 |
| DPS(Rs) | 3.50 | 5.00 | 3.00 | 3.00 | - |
| Book NAV/Share(Rs) | 445.98 | 334.36 | 241.15 | 166.32 | 116.30 |
| Tax Rate(%) | 22.70 | 25.53 | 25.26 | 25.41 | 125.09 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 30.01 | 28.81 | 28.27 | 29.15 | 21.35 |
| EBIT Margin(%) | 21.54 | 22.10 | 21.42 | 19.64 | 9.08 |
| Pre Tax Margin(%) | 17.80 | 19.50 | 18.43 | 16.06 | 4.10 |
| PAT Margin (%) | 13.76 | 14.52 | 13.77 | 11.98 | -1.03 |
| Cash Profit Margin (%) | 23.69 | 22.85 | 21.30 | 22.11 | 12.63 |
| Performance Ratios | |||||
| ROA(%) | 8.97 | 9.63 | 9.78 | 9.63 | -0.86 |
| ROE(%) | 29.80 | 34.28 | 38.56 | 36.29 | -2.60 |
| ROCE(%) | 33.26 | 38.59 | 42.98 | 42.40 | 16.92 |
| Asset Turnover(x) | 0.65 | 0.66 | 0.71 | 0.80 | 0.84 |
| Sales/Fixed Asset(x) | 0.79 | 0.79 | 0.81 | 0.89 | 0.95 |
| Working Capital/Sales(x) | -12.79 | -15.25 | -5.38 | -6.24 | -5.32 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.27 | 1.27 | 1.23 | 1.13 | 1.06 |
| Receivable days | 12.36 | 13.17 | 12.78 | 15.83 | 20.30 |
| Inventory Days | 10.64 | 9.00 | 7.98 | 9.93 | 17.22 |
| Payable days | 269.90 | 316.97 | 320.55 | 347.24 | 351.93 |
| Valuation Parameters | |||||
| PER(x) | 34.85 | 31.46 | 11.65 | 14.26 | - |
| PCE(x) | 20.24 | 19.99 | 7.53 | 7.72 | 8.33 |
| Price/Book(x) | 9.09 | 9.28 | 3.80 | 4.39 | 2.69 |
| Yield(%) | 0.09 | 0.16 | 0.33 | 0.41 | - |
| EV/Net Sales(x) | 5.01 | 4.62 | 1.66 | 1.72 | 1.05 |
| EV/Core EBITDA(x) | 15.91 | 15.19 | 5.74 | 5.79 | 4.61 |
| EV/EBIT(x) | 23.25 | 20.92 | 7.76 | 8.77 | 11.55 |
| EV/CE(x) | 6.50 | 7.08 | 2.84 | 1.04 | 0.88 |
| M Cap / Sales | 4.80 | 4.57 | 1.60 | 1.71 | 1.05 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 24.38 | 19.10 | 33.24 | 43.92 | -20.54 |
| Core EBITDA Growth(%) | 28.64 | 25.17 | 29.56 | 88.44 | -36.12 |
| EBIT Growth(%) | 21.25 | 22.82 | 45.34 | 211.36 | -55.51 |
| PAT Growth(%) | 17.88 | 25.57 | 53.20 | 1,775.24 | -110.51 |
| EPS Growth(%) | 17.88 | 25.57 | 53.20 | 1,775.24 | -110.51 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.46 | 0.33 | 0.39 | 0.41 | 0.40 |
| Current Ratio(x) | 0.64 | 0.85 | 0.48 | 0.61 | 0.63 |
| Quick Ratio(x) | 0.49 | 0.77 | 0.42 | 0.54 | 0.55 |
| Interest Cover(x) | 5.76 | 8.50 | 7.14 | 5.48 | 1.82 |
| Total Debt/Mcap(x) | 0.05 | 0.04 | 0.10 | 0.09 | 0.15 |
Compare Financial Ratios of peers of DR AGARWALS EYE HOSPITAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR AGARWALS EYE HOSPITAL | ₹2,250.7 Cr | 0.4% | -11.3% | 1.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹102,889.0 Cr | 3.2% | -3.9% | 4.2% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹101,192.0 Cr | 8.5% | 0.3% | -6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹64,620.6 Cr | 2% | -9% | 36.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,046.9 Cr | -2.8% | -10.7% | 28.2% | Stock Analytics | |
| GLOBAL HEALTH | ₹30,701.2 Cr | 0.2% | -7.7% | 3.3% | Stock Analytics | |
DR AGARWALS EYE HOSPITAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR AGARWALS EYE HOSPITAL | 0.4% |
-11.3% |
1.1% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses
